Please wait while we load the price list
Chain Drug Review - New warning for Strattera.(Digest)(Brief Article)
November 19th, 2008The Food and Drug Administration has ordered new warning labels concerning the potential for …
Most Popular
SWOT Analysis - To Make Your Business More Profitable
13 Job Interview Mistakes To Avoid
In the interest of the patient: Convergence across the pharmaceutical and healthcare industries
5 Regular Mistakes In Public Speaking
3 Questions No Job Seeker Ever Wants To Be Asked?
Read th…
Business Wire - Multimedia Available/FDA Approves Strattera, First Noncontrolled Option For Treatment of Attention-Deficit/Hyperactivity Disorder
November 13th, 2008 Business Editors & Health/Medical Writers
ADVISORY…for TUESDAY (Nov. 26)
NOTE TO EDITORS: Multimedia Assets Available With This Story
Include Logos, Text News Releases, Video
–(BUSINESS WIRE)
The U.S. Food and Drug Administration (FDA) today approved Stratter…
Business Wire - FDA Issues Approvable Letter for Strattera for ADHD; Strattera Would Give Patients, Families and Physicians a New Treatment Option
November 12th, 2008 Business & Health/Medical Editors
INDIANAPOLIS–(BW HealthWire)–Aug. 14, 2002
Eli Lilly and Company (NYSE:LLY) has received an approvable letter from the U.S. Food and Drug Administration (FDA) for Strattera(TM) (atomoxetine hydrochloride),…
Australasian Business Intelligence - Side-effect doubts over child drug.
November 8th, 2008Byline: Julie Robotham
Related Results
Finding …
M2 Presswire - Research and Markets : Strattera the most rapidly growing drug in the US ADHD market with 2004 revenues of $632m.
November 3rd, 2008 Most Popular
5 Regular Mistakes In Public Speaking
13 Job Interview Mistakes To Avoid
10 Jobs That Pay $30 An Hour
Public Speaking: 7 Secrets Of Great Public Speakers
3 Questions No Job Seeker Ever Wants To Be Asked?
…
Deseret News (Salt Lake City) - Strattera has drawbacks
October 29th, 2008I was disheartened by some aspects of your story in the July 12 edition touting Strattera as a wonder drug for ADHD. I do not mean to knock this medication. It is an excellent new addition to the group of medicines used to treat ADHD, and it has some definite advantages for some patients. There are, however, a few misleading aspects of the article. Of greatest concern is the implication that it has no side effects. In fact, the package insert clearly state…
Medical Marketing and Media - Lilly's Strattera ad gets FDA attention
October 23rd, 2008ELI LILLY SAYS a TV commercial for Strattera stopped running a month before FDA regulators asked it to pull the ad.
The ad, called “Video Game,” promotes Strattera for attention deficit disorder (ADD). However, Strattera is approved for children, adolescents and adults with attention deficit …
Youth Studies Australia - New drug for ADHD.(Health & safety)(Strattera)(Brief Article)
October 19th, 2008A new type of medication, sold as Strattera, has been launched for children suffering from Attention Deficit Hyperactivity Disorders. Strattera is unlike other medicines in that it contains no amphetamine or methylphenidate, which are both stimulants. Dr Michael McDowell, a Brisbane-based developmental paediatriclan who conducted clinical trials for the new medicine, said that excluding stimulants had eliminated the possibility of addiction.
…
Business Wire - Eli Lilly and Company: Strattera Prescriptions Double in Three-Month Period; Nonstimulant ADHD Medication’s Market Share Climbs to 16.3 Percent in September
October 13th, 2008 Business Editors/Health/Medical Writers
INDIANAPOLIS–(BUSINESS WIRE)–Oct. 16, 2003
In its first nine months on the market, doctors have written more than 2 million prescriptions for Strattera(R) (atomoxetine HCl), the only nonstimulant medicine approved for th…
USA TODAY - FDA: Strattera may carry risk of suicide
October 8th, 2008 The attention-deficit drug Strattera may prompt children and teens to consider or attempt suicide, the Food and Drug Administration warned Thursday.
The FDA ordered Strattera’s maker, Eli Lilly & Co., to add a “black box” warning, the FDA’s strongest alert, to the drug’s label. It advises doctors and patients to be on guard for mood changes or suicidal thinking.
Doctors last year …
